Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ZVRA holding history

Zevra Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ZVRA overviewAll 13F holders of ZVRAFull Q2 2026 holdings

Shares (Q2 2026)
144,834
Value
$2.08M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of ZVRA by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026144,834$2.08M<0.1%−277,214−65.7%ReducedHolders
Q1 2026422,048$3.93M<0.1%+136,560+47.8%AddedHolders
Q4 2025285,488$2.56M<0.1%+67,392+30.9%AddedHolders
Q3 2025218,096$2.07M<0.1%+63,912+41.5%AddedHolders
Q2 2025154,184$1.36M<0.1%−8,880−5.4%ReducedHolders
Q1 2025163,064$1.22M<0.1%−180,754−52.6%ReducedHolders
Q4 2024343,818$2.87M<0.1%+323,884+1,624.8%AddedHolders
Q3 202419,934$138.3K<0.1%+7,002+54.1%AddedHolders
Q2 202412,932$63.4K<0.1%−30,016−69.9%ReducedHolders
Q1 202442,948$249.1K<0.1%+7,838+22.3%AddedHolders
Q4 202335,110$230.0K<0.1%+16,368+87.3%AddedHolders
Q3 202318,742$90.3K<0.1%−1,350−6.7%ReducedHolders
Q2 202320,092$102.5K<0.1%+15,953+385.4%AddedHolders
Q1 20234,139$22.8K<0.1%−2,842−40.7%ReducedHolders
Q4 20226,981$32.0K<0.1%+6,004+614.5%AddedHolders
Q3 2022977$6.00K<0.1%−4,821−83.1%ReducedHolders
Q2 20225,798$26.0K<0.1%+5,798NewHolders
Q1 20220$00.0%−10,499−100.0%Sold outHolders
Q4 202110,499$92.0K<0.1%+10,499NewHolders
Q2 20210$00.0%−13,283−100.0%Sold outHolders
Q1 202113,283$122.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.